Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy in patients with resectable MAGE-A3 positive Non-Small Cell Lung Cancer
GSK1572932A
109493
NCT00480025
Lung Cancer, Non-Small Cell
Phase 3
 
May 2017

Powered by ideaPoint, Inc.